GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indo-Bangla Pharmaceuticals Ltd (DHA:IBP) » Definitions » DeferredTaxAndRevenue

Indo-Bangla Pharmaceuticals (DHA:IBP) DeferredTaxAndRevenue : BDT0.00 Mil (As of . 20)


View and export this data going back to 2018. Start your Free Trial

What is Indo-Bangla Pharmaceuticals DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Indo-Bangla Pharmaceuticals's current deferred tax and revenue for the quarter that ended in . 20 was BDT0.00 Mil.

Indo-Bangla Pharmaceuticals DeferredTaxAndRevenue Historical Data

The historical data trend for Indo-Bangla Pharmaceuticals's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indo-Bangla Pharmaceuticals DeferredTaxAndRevenue Chart

Indo-Bangla Pharmaceuticals Annual Data
Trend
DeferredTaxAndRevenue

Indo-Bangla Pharmaceuticals Semi-Annual Data
DeferredTaxAndRevenue

Indo-Bangla Pharmaceuticals DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of Indo-Bangla Pharmaceuticals's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Indo-Bangla Pharmaceuticals (DHA:IBP) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Plot No. 183, 6th Floor, Block B, Ahmed Akbar Sobhan Road, Bashundhara R/A, Baridhara, Dhaka, BGD, 1229
Indo-Bangla Pharmaceuticals Ltd is engaged in manufacturing, marketing and distribution of generic pharmaceuticals products which includes human drugs dosages form such as tablet, capsule, syrup, oral saline, suspension. The products of the company are sold in domestic market. The company has also applied for permission for production and selling of veterinary medicine.